Inventor · disambiguated record
John J. Nestor
Also filed as: NESTOR JOHN · NESTOR JOHN J · NESTOR JOHN JOSEPH · NESTOR JR JOHN J
53 granted patents·24 pending applications·2,281 citations·filing 1976–2025
99Inventor score
Files withSYNTEX INC39MEDERIS DIABETES LLC13FORBES MEDI TECH RES INC5TRANSITION THERAPEUTICS INC4EUMEDERIS PHARMACEUTICALS INC2
Top patents by PatentIndex Score
77 records- 0198US4667014ANonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonistsSYNTEX INC·Filed 1983·Granted May 19, 1987·258 cites·12 claims
- 0297US4234571ANonapeptide and decapeptide derivatives of luteinizing hormone releasing hormoneSYNTEX INC·Filed 1979·Granted Nov 18, 1980·88 cites·15 claims
- 0396US4082736ANovel immunological adjuvant compounds and methods of preparation thereofSYNTEX INC·Filed 1976·Granted Apr 4, 1978·78 cites·51 claims
- 0496US4082735ANovel immunological adjuvant compounds and methods of preparation thereofSYNTEX INC·Filed 1976·Granted Apr 4, 1978·71 cites·50 claims
- 0595US5693616AAnalogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosisSYNTEX INC·Filed 1995·Granted Dec 2, 1997·95 cites·27 claims
- 0695US5589452AAnalogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosisSYNTEX INC·Filed 1992·Granted Dec 31, 1996·105 cites·37 claims
- 0795US4493795ASynthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufactureSYNTEX INC·Filed 1983·Granted Jan 15, 1985·191 cites·4 claims
- 0894US11541028B2Peptide pharmaceuticals for treatment of NASH and other disordersMEDERIS DIABETES LLC·Filed 2019·Granted Jan 3, 2023·8 cites·6 claims
- 0994US10420844B2Peptide pharmaceuticalsMEDERIS DIABETES LLC·Filed 2018·Granted Sep 24, 2019·6 cites·22 claims
- 1094US4530920ANonapeptide and decapeptide analogs of LHRH, useful as LHRH agonistSYNTEX INC·Filed 1983·Granted Jul 23, 1985·54 cites·23 claims
- 1193US12257229B2Peptide pharmaceuticals for treatment of NASH and other disordersMEDERIS DIABETES LLC·Filed 2022·Granted Mar 25, 2025·1 cites·15 claims
- 1293US7595294B2Vasoactive intestinal polypeptide pharmaceuticalsTRANSITION THERAPEUTICS INC·Filed 2006·Granted Sep 29, 2009·14 cites·9 claims
- 1393US5807823AAnalogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosisSYNTEX INC·Filed 1995·Granted Sep 15, 1998·71 cites·10 claims
- 1492US10010617B2Peptide pharmaceuticalsNESTOR JOHN J·Filed 2012·Granted Jul 3, 2018·10 cites·9 claims
- 1592US5840837AAnalogs of parathyroid hormone and parathyroid hormone relate peptide synthesis and use for the treatment of osteoporosisSYNTEX INC·Filed 1995·Granted Nov 24, 1998·71 cites·8 claims
- 1692US5798225AProcess for recombinant production of PTH and PTHrp analogsSYNTEX INC·Filed 1995·Granted Aug 25, 1998·72 cites·3 claims
- 1791US5977070APharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosisFiled 1995·Granted Nov 2, 1999·154 cites·13 claims
- 1891US5695955AAnalogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosisSYNTEX INC·Filed 1995·Granted Dec 9, 1997·69 cites·17 claims
- 1990US5874086ASynthesis and use for the treatment of osteoporosisSYNTEX INC·Filed 1994·Granted Feb 23, 1999·53 cites·14 claims
- 2089US10577405B2Peptide pharmaceuticals for insulin resistanceMEDERIS DIABETES LLC·Filed 2017·Granted Mar 3, 2020·6 cites·16 claims
- 2189US10005817B2Peptide pharmaceuticalsEUMEDERIS PHARMACEUTICALS INC·Filed 2013·Granted Jun 26, 2018·9 cites·24 claims
- 2289US9856306B2Peptide pharmaceuticals for insulin resistanceSPITFIRE PHARMA INC·Filed 2015·Granted Jan 2, 2018·12 cites·13 claims
- 2389US7566691B2Vasoactive intestinal polypeptide pharmaceuticalsTRANSITION THERAPEUTICS INC·Filed 2005·Granted Jul 28, 2009·17 cites·9 claims
- 2489US6083953A2- (2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3- propanediol derivativeSYNTEX INC·Filed 1997·Granted Jul 4, 2000·51 cites·6 claims
- 2589US6051686AAnalogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosisSYNTEX INC·Filed 1995·Granted Apr 18, 2000·58 cites·15 claims
- 2687US2025313604A1Peptide pharmaceuticals for insulin resistanceMEDERIS DIABETES LLC·Filed 2024·Application pending·0 cites
- 2787US2025136656A1Peptide pharmaceuticals for insulin resistanceMEDERIS DIABETES LLC·Filed 2024·Application pending·0 cites
- 2886US11065304B2Peptide pharmaceuticals for insulin resistanceMEDERIS DIABETES LLC·Filed 2013·Granted Jul 20, 2021·4 cites·20 claims
- 2986US4686283AAnalogs of transforming and epidermal growth factor fragments for therapy and diagnosisSYNTEX INC·Filed 1985·Granted Aug 11, 1987·67 cites·33 claims
- 3086US4318905ANonapeptide and decapeptide agonists of luteinizing hormone releasing hormone containing heterocyclic amino acid residuesSYNTEX INC·Filed 1980·Granted Mar 9, 1982·17 cites·22 claims
- 3185US5872113AFluorinated vitamin D3 analogsSYNTEX INC·Filed 1997·Granted Feb 16, 1999·29 cites·27 claims
- 3285US4801577ANonapeptide and decapeptide analogs of LHRH useful as LHRH antagonistsSYNTEX INC·Filed 1987·Granted Jan 31, 1989·50 cites·41 claims
- 3385US4690916ANona and decapeptide analogs of LHRH useful as LHRH antagonistsSYNTEX INC·Filed 1984·Granted Sep 1, 1987·28 cites·13 claims
- 3483US4256737ALong acting depot injectable formulations for LH-RH analoguesSYNTEX INC·Filed 1979·Granted Mar 17, 1981·39 cites·1 claims
- 3580US10471127B2Peptide pharmaceuticals for insulin resistanceNESTOR JOHN J·Filed 2012·Granted Nov 12, 2019·6 cites·20 claims
- 3679US4481190ANonapeptide and decapeptide analogs of LHRH useful as LHRH antagonistsSYNTEX INC·Filed 1982·Granted Nov 6, 1984·44 cites·17 claims
- 3778US5783179AC-reactive protein fragment with immunomodulatory activitySYNTEX INC·Filed 1991·Granted Jul 21, 1998·49 cites·15 claims
- 3878US5543414AAchiral amino acid acyl esters of ganciclovir and its derivativesSYNTEX INC·Filed 1994·Granted Aug 6, 1996·38 cites·25 claims
- 3977US4341767ANonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonistsSYNTEX INC·Filed 1980·Granted Jul 27, 1982·41 cites·21 claims
- 4076US4473555ANona- and dodecapeptides for augmenting natural killer cell activitySYNTEX INC·Filed 1983·Granted Sep 25, 1984·19 cites·6 claims
- 4175US11911447B2Peptide pharmaceuticals for insulin resistanceMEDERIS DIABETES LLC·Filed 2021·Granted Feb 27, 2024·0 cites·18 claims
- 4275US6034137ACationic lipids for gene therapySYNTEX INC·Filed 1997·Granted Mar 7, 2000·45 cites·12 claims
- 4375US4659693AN,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptidesSYNTEX INC·Filed 1985·Granted Apr 21, 1987·37 cites·26 claims
- 4475US2020289653A1Improved peptide pharmaceuticals for insulin resistanceMEDERIS DIABETES LLC·Filed 2020·Application pending·0 cites
- 4571US7189748B2Compounds and methods for treating insulin resistance and cardiomyopathyFORBES MEDI TECH RES INC·Filed 2005·Granted Mar 13, 2007·3 cites·26 claims
- 4671US4859765ASynthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufactureSYNTEX INC·Filed 1984·Granted Aug 22, 1989·29 cites·5 claims
- 4769US5856481A2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivativeSYNTEX INC·Filed 1997·Granted Jan 5, 1999·8 cites·20 claims
- 4869US2021077629A1Improved peptide pharmaceuticalsMEDERIS DIABETES LLC·Filed 2019·Application pending·0 cites
- 4968US5840891A2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivativeSYNTEX INC·Filed 1997·Granted Nov 24, 1998·7 cites·6 claims
- 5068US4581169ANona-peptide and deca-peptide analogs of LHRH, useful as LHRH antagonistsSYNTEX INC·Filed 1983·Granted Apr 8, 1986·21 cites·1 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →